Aug. 15, 2012
-- NEEDHAM, MASS. – Cambridge Healthtech Institute releases complimentary podcast featuring Amelia Warner, Pharm.D., Head, Clinical Pharmacogenomics and Clinical Specimen Management, Global Clinical Development and Regulatory Affairs, Merck, discussing Biosamples to Pharmacogenomics.
Amelia Warner will be speaking on Retrospective Analysis: Contribution and Implementation in Drug Development during the opening plenary session at CHI's upcoming 4th Annual Leaders in Biobanking Congress.
The 4th International Leaders in Biobanking Congress will address both the business and science of biobanking, bringing together biomedical and biopharmaceutical researchers, regulators, biorepository managers, and practitioners to investigate the best tactics for effective use of biospecimens within today's cutting edge research. This conference takes place October 1-2, 2012 in Chapel Hill, NC.
Advance registration discounts are available until August 24, 2012. To view the entire conference agenda and to register, please visit http://www.healthtech.com/biobanking
About Cambridge Healthtech Institute (www.chicorporate.com)
Cambridge Healthtech Institute (CHI) is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech and academic organizations. CHI’s portfolio of products includes Cambridge Healthtech Institute Conferences, Insight Pharma Reports, Barnett International, Cambridge Marketing Consultants, Cambridge Meeting Planners and Cambridge Healthtech’s Media Group, which includes numerous e-newsletters as well as Bio-IT World magazine.
Founded in 1992, Cambridge Healthtech Institute strives to develop quality information sources that provide valuable new insights and competing points of view while offering balanced coverage of the latest developments. Basic research related to commercial implications is covered, with heavy emphasis placed on end-user insights into new products and technology as well as coverage on the strategy behind the business.